FK 506-associated diabetes mellitus in the pediatric transplant population is a rare complication.
作者信息
Carroll P B, Rilo H, Reyes J, Alejandro R, Zeng Y, Ricordi C, Tzakis A, Shapiro R, Starzl T E
机构信息
Department of Medicine, University of Pittsburgh Medical School, PA.
出版信息
Transplant Proc. 1991 Dec;23(6):3171-2.
Abstract
摘要
相似文献
1
FK 506-associated diabetes mellitus in the pediatric transplant population is a rare complication.儿童移植人群中与FK 506相关的糖尿病是一种罕见的并发症。
Transplant Proc. 1991 Dec;23(6):3171-2.
2
Diabetes as a complication of tacrolimus (FK506) in pediatric renal transplant patients.糖尿病作为小儿肾移植患者使用他克莫司（FK506）的并发症。
Pediatr Nephrol. 1996 Feb;10(1):64-6. doi: 10.1007/BF00863448.
3
Tacrolimus to cyclosporine microemulsion formulation conversion in the pediatric liver transplant patient.小儿肝移植患者从他克莫司转换为环孢素微乳剂配方
Transplant Proc. 1998 Aug;30(5):1964-6. doi: 10.1016/s0041-1345(98)00497-7.
4
Disappearance of diabetes mellitus after conversion from FK 506 to Neoral in two liver transplanted patients.两名肝移植患者从他克莫司（FK 506）转换为新山地明后糖尿病消失。
Transplant Proc. 1998 Aug;30(5):1863-4. doi: 10.1016/s0041-1345(98)00461-8.
5
New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients.接受他克莫司（FK 506）与环孢素治疗的肾移植受者新发糖尿病情况。
Transplant Proc. 1991 Dec;23(6):3169-70.
6
New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression.接受以他克莫司为基础的免疫抑制治疗的小儿胸器官受者新发糖尿病
J Heart Lung Transplant. 1997 Mar;16(3):275-82.
7
Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.他克莫司在胰腺移植中的应用：一项多中心分析。他克莫司胰腺移植研究组。
Clin Transplant. 1997 Aug;11(4):299-312.
8
Conversion of pancreas transplants to FK 506 from CsA.胰腺移植从环孢素A转换为他克莫司（FK 506）。
Transplant Proc. 1995 Dec;27(6):3032-3.
9
Neurologic complications of FK 506.FK506的神经并发症
Transplant Proc. 1991 Dec;23(6):3175-8.
10
FK 506 in kidney transplantation: results of the U.S.A. randomized comparative phase III study. The FK 506 Kidney Transplant Study Group.FK506用于肾移植：美国随机对照III期研究结果。FK506肾移植研究组。
Transplant Proc. 1997 Feb-Mar;29(1-2):304-5. doi: 10.1016/s0041-1345(96)00270-9.
引用本文的文献
1
Incidence of hyperglycemia and diabetes and association with electrolyte abnormalities in pediatric solid organ transplant recipients.儿童实体器官移植受者高血糖和糖尿病的发生率及与电解质异常的关系。
Nephrol Dial Transplant. 2017 Sep 1;32(9):1579-1586. doi: 10.1093/ndt/gfx205.
2
The role of environmental factors in insulin-dependent diabetes mellitus: an unresolved issue.环境因素在胰岛素依赖型糖尿病中的作用：一个尚未解决的问题。
Environ Health Perspect. 1999 Oct;107 Suppl 5(Suppl 5):777-81. doi: 10.1289/ehp.99107s5777.
3
Pediatric renal transplantation under tacrolimus-based immunosuppression.基于他克莫司的免疫抑制下的小儿肾移植
Transplantation. 1999 Jan 27;67(2):299-303. doi: 10.1097/00007890-199901270-00020.
4
Clinical islet cell transplantation. Are we there yet?临床胰岛细胞移植。我们成功了吗？
Int J Pancreatol. 1998 Dec;24(3):145-68. doi: 10.1007/BF02788418.
5
Diabetes as a complication of tacrolimus (FK506) in pediatric renal transplant patients.糖尿病作为小儿肾移植患者使用他克莫司（FK506）的并发症。
Pediatr Nephrol. 1996 Feb;10(1):64-6. doi: 10.1007/BF00863448.
6
Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression.在FK 506免疫抑制下肾移植后非裔美国人的移植后糖尿病
Transplant Proc. 1993 Aug;25(4):2433-4.
7
Long-term insulin requirement after liver transplantation with FK 506 in American veterans.美国退伍军人肝移植后使用FK 506的长期胰岛素需求情况。
Transplant Proc. 1993 Feb;25(1 Pt 1):677-8.
8
Two-year experience with FK 506 in pediatric patients.FK506在儿科患者中的两年应用经验。
Transplant Proc. 1993 Feb;25(1 Pt 1):619-21.
9
Clinical use of tacrolimus (FK-506) in infants and children with renal transplants.
Pediatr Nephrol. 1995 Aug;9(4):487-94. doi: 10.1007/BF00866738.
10
Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.他克莫司。其药理学及在肝移植和肾移植中的治疗潜力综述。
Drugs. 1993 Oct;46(4):746-94. doi: 10.2165/00003495-199346040-00009.
本文引用的文献
1
Toxicity of FK-506 in human fetal pancreas.FK-506对人胎儿胰腺的毒性
Diabetes. 1989 Jan;38 Suppl 1:172-5. doi: 10.2337/diab.38.1.s172.
2
Kidney transplantation in the dog receiving FK-506.接受FK-506的犬类肾脏移植
Transplant Proc. 1987 Oct;19(5 Suppl 6):62.
3
Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A.FK-506对体外淋巴细胞同种异体激活的免疫抑制作用：与环孢素A的协同作用。
Transplant Proc. 1987 Oct;19(5 Suppl 6):40-4.
4
The effect of FK 506 on canine pancreatic islet cell function in beagle dogs.FK506对比格犬胰岛细胞功能的影响。
Transplant Proc. 1991 Feb;23(1 Pt 1):756-7.
5
Glycemia and insulin need following FK 506 rescue therapy in liver transplant recipients.肝移植受者接受FK 506挽救治疗后的血糖水平和胰岛素需求情况。
Transplant Proc. 1991 Feb;23(1 Pt 2):949-53.
6
Effect of the immunosuppressant FK506 on glucose-induced insulin secretion from adult rat islets of Langerhans.免疫抑制剂FK506对成年大鼠胰岛葡萄糖诱导的胰岛素分泌的影响。
Transplantation. 1991 Jan;51(1):275-8. doi: 10.1097/00007890-199101000-00048.
7
In vitro effects of FK-506 on human and rat islets.FK-506对人及大鼠胰岛的体外作用。
Transplantation. 1990 Jun;49(6):1172-4. doi: 10.1097/00007890-199006000-00030.
8
Pharmacokinetics of FK 506: preclinical and clinical studies.FK506的药代动力学：临床前和临床研究。
Transplant Proc. 1990 Feb;22(1):52-6.
9
Oral glucose tolerance test in liver recipients treated with FK 506.接受FK 506治疗的肝移植受者的口服葡萄糖耐量试验。
Transplant Proc. 1990 Feb;22(1):41-3.
Zotero 插件